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Letters
Neural Networks, Logistic Regression, and
Calibration: A Reply
To the Editor: -Steyerberg, Harrell, and Goodman’
have commented about the model calibration, neural net-
work design, and logistic regression models in our study,
which used neural networks to predict perioperative car-
diac risk.2 2
They maintain that the likelihood-ratio calculations
were invalid unless the neural network scores had nor-
mal distributions for patients with and without cardiac
events.’ However, in our study we examined these distri-
butions and they were indeed normal.
Obtaining likelihood ratios from neural networks was
described as a superfluous step because neural networks
can provide logistic probabilities.’ However, many neural
network designs do not provide such probabilities. Dif-
ferent transfer functions may produce neural network
outputs greater than one or less than zero.
In our experience, the availability of different neural
network transfer functions gives the investigator an im-
portant degree of versatility, with potential effects on
model performance. With our method, the investigator
does not need to rely on the NevProp software’ of Dr.
Goodman. The nature of the &dquo;more advanced func-
tionality&dquo;’ of NevProp3 as compared with NeuralWare
software’ is unclear.
A concern about model calibration was also expressed.
It was felt that the development of two separate models
(one with six clinical predictors and a second with three
dipyridamole thallium parameters) may have been inher-
ently problematic.’ However, in our experience with these
data, we did not find better calibration through a single-
step approach. Most important, the clinician may choose
to defer dipyridamole thallium testing in patients whose
six clinical predictors suggest low risk. The development
of two separate models is preferable because it has
greater clinical relevance.
The use of external validation was described as &dquo;quite
common nowadays, but statistically inefficient compared
to e.g. bootstrapping. &dquo; Again, clinical relevance is an is-
sue. The ability to develop a model based on information
from one hospital and implement it in evaluating data
from another institution is a meaningful clinical issue that
we addressed in our study. Careful attention to such clin-
ical issues shaped many of the other design choices in the
original model development and validation provided by
L’Italien et al.s
Steyerberg, Harrell, and Goodman provide further
comments on the development of logistic regression
models, proposing alternative methods and suggesting
that in comparison neural networks might not have
seemed so impressive.’ This type of response to neural
network studies is quite common. The reader feels that if
only a more advanced statistical method had been em-
ployed, then the performance difference might have been
eliminated. This approach misses the point of our work.
Our goal was to examine a previously implemented,
successful, published statistical approach’ and determine
whether a neural network model could offer any differ-
ences in model performance. We feel that relevant differ-
ences were indeed shown. The neural network therefore
offers one option for model refinement. This does not
mean that there are no other statistical options with lo-
gistic regression. Nor can we exclude other neural net-
work modeling options that were not evaluated in the
study.
This research should not be envisioned as a contest
between the best possible neural network and the best
possible statistical model, but rather as a study of how an
investigator might use neural networks to refine model
performance. In this respect, a neural network approach
may not be inherently &dquo;superior,&dquo; but with existing soft-
ware it may indeed be practical and useful. Neural net-
works have attracted substantial interest because they
readily provide the PC user with powerful and advanced
models. Neural networks merit further development and
evaluation in the field of medical decision making.
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Neural Networks, Logistic Regression, and
Calibration: A Rejoinder
To the Editor: -In closing this discussion about cali-
bration of neural networks (NNs) and logistic regression,
it is not necessary to reiterate all criticisms mentioned
before. The reader can contemplate some of the minor
issues, such as the pros and cons of using specific neural
network software.’ Rather, we would like to expand on
the more general issues on prognostic modeling with NNs
or logistic regression techniques.
Lapuerta et al. reply that their research should not be
envisioned as a contest between the best possible neural
network and logistic regression model.’ In their study, a
comparison was made between a poorly validating neural
network and a very poorly validating logistic regression
model; indeed, these models were far from the best pos-
sible, for reasons indicated before. It makes little sense to
compare methodologic aspects of two techniques when
at least one is applied in a simplistic way. One should not
ignore the advances in regression modeling that have
been made over the past 10 years.4 4
Regarding model validation, our remarks on bootstrap-
ping should not be misunderstood as not clinically rele-
vant. Statistical issues related to internal validity should
be distinguished from clinical issues relating to external
validity. Internal validity refers to the performance of the
model (e.g., calibration, ROC area) in the underlying pa-
tient population from which the sample used to construct
the model was drawn. Bootstrapping is currently the most
efficient way to assess internal validity. A bootstrap esti-
mate of internal validity will be less favorable than the
apparent validity estimated directly on the sample. The
latter estimate is over-optimistic, especially when the data
set is small.
External validity, or generalizability, refers to validity in
another population, for example, in patients seen more
recently (time difference), or at different centers (place
difference). Several mechanisms (referral patients, regis-
tration of predictors, treatment differences, etc.) may lead
to differences in prognostic relationships, causing exter-
nal validity to be most likely less than internal validity.
Internal validity will imply external validity only when dif-
ferences in time and place are negligible. When time or
place effects are present, they can be incorporated in the
model so that valid predictions can be obtained for an-
other population.’
In the original publication of L’Italien et al. it was ar-
gued that comparability may be assumed between train-
ing (two hospitals) and validation samples (three other
hospitals).s This implies that the patients in the five hos-
pitals were regarded as originating from a common un-
derlying population. The evaluation thus concerned es-
sentially internal validation, and bootstrapping of a model
based on the full data set would have been more efficient.
If one is interested in assessing external validity, inter-
nal validity should first be assessed in a training sample
(e.g., by bootstrapping). Subsequently one might compare
the estimated internal validity with the estimate in a val-
idation sample. Large sample sizes will be required to
determine differences between internal and external va-
lidity with some certainty.
In conclusion, assessment of internal and external va-
lidity should not be mixed up in one step, and the boot-
strap has a clear place in model validation.’ When mod-
ern methods such as NNs are applied, an up-to-date
approach to regression analysis should be used in any
comparisons. Any advantages of NNs may then appear to
be restricted to patient populations with highly nonlinear
prognostic relationships and important higher-order in-
teractions that are not easily captured in regression mod-
els.l’
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